| Literature DB >> 36249806 |
Xiangyuan Zhang1,2, Lili Zhang1, Boxun Zhang1, Ke Liu1, Jun Sun3, Qingwei Li1, Linhua Zhao1.
Abstract
Type 2 diabetes mellitus (T2DM) is a metabolic, endocrine disease characterized by persistent hyperglycemia. Several studies have shown that herbal tea improves glucose metabolism disorders in patients with T2DM. This study summarizes the published randomized controlled trials (RCTs) on herbal tea as a adjuvant therapy for treating T2DM and found that herbal teas have potential add-on effects in lowering blood glucose levels. In addition, we discussed the polyphenol contents in common herbal teas and their possible adverse effects. To better guide the application of herbal teas, we further summarized the hypoglycemic mechanisms of common herbal teas, which mainly involve: 1) improving insulin resistance, 2) protecting islet β-cells, 3) anti-inflammation and anti-oxidation, 4) inhibition of glucose absorption, and 5) suppression of gluconeogenesis. In conclusion, herbal tea, as a novel adjuvant therapy for treating T2DM, has the potential for further in-depth research and product development.Entities:
Keywords: herbal tea; mechanism; randomized controlled trial; review; type 2 diabetes
Year: 2022 PMID: 36249806 PMCID: PMC9561533 DOI: 10.3389/fphar.2022.982387
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.988
Effectiveness of HTs in the management of T2DM.
| Trials | Herbal Tea name | No of patients | Sex(male/female) | Age(years) | Treatment | Treament time | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| text group | Control group | text group | Control group | text group | Control group | text group | Control group | |||||
|
| Mulberry leaf tea | 40 | 40 | 26/14 | 24/16 | 53.88 ± 14.31 | 54.08 ± 12.74 | Conventional treatment + Metformin sustained-release tablets 0.5 g/Bid + Mulberry tea | Conventional treatment + Metformin sustained-release tablets 0.5 g/Bid | 3 months | 12 weeks | |
| Yang et al., (2019) | Mulberry leaf tea | 50 | 50 | 24/26 | 27/23 | 43.20 ± 10.72 | 43.58 ± 10.12 | Conventional treatment + Mulberry leaf Black Tea | Conventional treatment | 6 months | 24 weeks | |
| Rafraf M et al., (2015) | Chamomile tea | 32 | 32 | 6/26 | 6/26 | 50.19 ± 7.08 | 51.97 ± 6.42 | Chamomile Tea | Warm water | 2 months | 8 weeks | |
| Kaseb et al., (2018) | Chamomile tea | 25 | 25 | - | - | 55.33 ± 7.85 | 55.22 ± 6.72 | Chamomile Tea | Conventional treatment | 1 month | 4 weeks | |
|
| Gynostemma tea | 12 | 12 | 8/4 | 9/3 | 63.5 ± 6.5 | 57.2 ± 8.2 | Gynostemma pentaphyllum Tea | Placebo | 3 months | 12 weeks | |
|
| Yerba mate tea | 11 | 9 | 1/10 | 4/5 | 54.3 ± 6.9 | 60 ± 6.7 | Mate tea | Dietary intervention | 2 months | 60 days | |
|
| Kothala himbutu tea | 28 | 23 | 16/12 | 12/11 | 53.2 ± 7.5 | 54.3 ± 6.9 | Kothala Himbutu Tea | placebo | 3 months | 12 weeks | |
|
| Puda tea | 38 | 32 | 12/26 | 9/23 | 53.77 ± 9.18 | 58.97 ± 9.07 | Puda Tea | Placebo | 1 month | 4 weeks | |
|
| Rauvolfia-Citrus tea | 12 | 11 | 6/5 | 7/5 | 63.4 ± 8.8 | 63.9 ± 5.2 | Rauvolfia-Citrus Tea | Placebo | 4 months | 16 weeks | |
| Yue et al., 2018 | Tuckwheat yuzhu tea | 53 | 52 | - | - | 76.63 ± 7.01 | 76.63 ± 7.01 | Conventional treatment + Tartary Buckwheat Polygonatum Tea | Conventional treatment | 6 months | 24 weeks | |
| Liu et al., (2018) | Mulberry black tea | 20 | 20 | - | - | - | - | Metformin tablets +Compound Danshen Dripping Pills +Mulberry Black Tea | Metformin tablets +Compound Danshen Dripping Pills | 3 months | 12 weeks | |
|
| Shuning tea | 18 | 15 | 8/10 | 6/9 | 58.3 | 57.4 | Metformin tablets + Shu Ning Tea | Metformin tablets | 1 month | 4 weeks | |
| Han et al., (2015) | Zhongyue jiangsangao tea | 30 | 30 | 17/13 | 16/14 | 44.8 ± 8.4 | 45.1 ± 7.9 | Metformin tablets + Yuejiang Sangao Herbal Tea | Metformin tablets | 3 months | 12 weeks | |
|
| Tianhan diabetes tea | 52 | 52 | 13/39 | 15/37 | 56.71 ± 7.52 | 54.20 ± 6.00 | Tianhan diabetes Tea | Blank control | 2 months | 8 weeks | |
| Mahmoud F et al., 2016 | Diabetes tea | 30 | 20 | - | - | 51.5 | 54.2 | Diabete Tea extract | Placebo | 3 months | 12 weeks | |
| Wen et al., (2018) | Self-developed herbal tea | 50 | 50 | 12/38 | 16/34 | 67.26 ± 7.10 | 65.81 ± 6.58 | Acupoint self-massage + Herbal Tea | Acupoint self-massage | 6 months | 24 weeks | |
|
| Mulberry leaf tea | 6.74 ± 1.22 | 6.93 ± 1.60 | 6.86 ± 0.96 | 6.87 ± 1.11 | 9.49 ± 3.06 | 9.79 ± 2.95 | 7.83 ± 3.74 | 9.76 ± 3.72 | 2.45 ± 1.43 | 3.19 ± 1.66 | 3 |
| Yang et al., (2019) | Mulberry leaf tea | 5.73 ± 1.15 | 6.52 ± 1.34 | 6.05 ± 0.67 | 6.31 ± 0.58 | 7.29 ± 1.16 | 8.96 ± 1.25 | - | - | - | - | 4 |
| Rafraf M et al., (2015) | Chamomile tea | 8.89 ± 3.7 | 8.74 ± 1.56 | 7.48 ± 1.59 | 7.50 ± 0.92 | - | - | - | - | 4.24 ± 1.95 | 5.55 ± 1.12 | 4 |
| Kaseb et al., (2018) | Chamomile tea | 8.16 ± 0.37 | 9.05 ± 0.37 | - | - | 12.35 ± 0.61 | 13.20 ± 0.61 | - | - | - | - | 4 |
|
| Gynostemma tea | 7.0 ± 1.4 | 8.7 ± 2.2 | 7.4 ± 1.0 | 8.1 ± 1.3 | - | - | - | - | 4.82 ± 2.64 | 6.89 ± 3.8 | 7 |
|
| Yerba mate tea | - | - | - | - | - | - | - | - | - | - | 2 |
|
| Kothala himbutu tea | - | - | 6.29 ± 1.02 | 6.65 ± 1.04 | - | - | - | - | - | - | 6 |
|
| Puda tea | 9.16 ± 3.66 | 12.14 ± 3.23 | - | - | 14.4 ± 13.41 | 20.01 ± 4.52 | 8.70 ± 5.09 | 8.50 ± 4.60 | - | - | 3 |
|
| Rauvolfia-Citrus tea | 7.7 ± 2.2 | 8.1 ± 2.1 | 6.1 ± 1.2 | 6.7 ± 1.1 | 14.5 ± 5.5 | 15.8 ± 3.8 | 11 ± 4 | 7 ± 3 | - | - | 7 |
| Yue et al., 2018 | Tuckwheat yuzhu tea | 7.71 ± 2.01 | 8.52 ± 2.32 | 8.12 ± 1.71 | 8.63 ± 1.62 | - | - | - | - | - | - | 4 |
| Liu et al., (2018) | Mulberry black tea | 6.47 ± 1.09 | 7.31 ± 1.42 | 6.01 ± 0.58 | 6.42 ± 0.65 | 8.21 ± 1.34 | 9.13 ± 1.50 | - | - | - | - | 3 |
| Fang 2001 | Shuning tea | 8.0 ± 1.7 | 9.5 ± 1.9 | - | - | 9.3 ± 2.6 | 10.1 ± 2.3 | - | - | - | - | 2 |
| Han et al., (2015) | Zhongyue jiangsangao tea | 7.2 ± 2.3 | 9.8 ± 2.9 | - | - | 9.8 ± 2.1 | 12.4 ± 2.7 | 7.2 ± 1.4 | 9.2 ± 1.4 | 3.2 ± 1.0 | 4.3 ± 1.5 | 1 |
|
| Tianhan diabetes tea | 6.38 ± 2.25 | 8.12 ± 3.25 | 6.21 ± 0.93 | 6.08 ± 1.14 | 9.96 ± 2.55 | 11.25 ± 3.08 | - | - | - | - | 1 |
| Mahmoud F et al., 2016 | Diabetes tea | 8.7 ± 0.38 | 8.12 ± 57 | 8.26 ± 0.21 | 7.70 ± 0.37 | - | - | - | - | - | - | 3 |
| Wen et al., (2018) | Self-developed herbal tea | 7.12 ± 0.35 | 7.02 ± 1.02 | 6.12 ± 0.35 | 7.02 ± 1.02 | 10.12 ± 0.35 | 11.02 ± 1.02 | - | - | - | - | 1 |
Herbs in HTs for the treatment of T2DM.
| Herbal tea name | Composition | Parts | |
|---|---|---|---|
| Single Herbal Tea | Mulberry leaf tea | Morus alba L. | leaf |
| Chamomile tea |
| flower | |
| Gynostemma pentaphyllum tea | Gynostemma pentaphyllum (Thunb.) Makino. | leaf | |
| Yerba mate tea | Ilex paraguariensis A.St.-Hil. | leaf | |
| Kothala himbutu tea | Salacia renetulata Wight. | root and stem | |
| Puda tea | Momordica charantia L. | fruit | |
| Compound Herbal Tea | Rauvolfia-Citrus tea | Rauvolfia vomitoria Wennberg | foliage |
| Citrus × aurantium L. | fruit | ||
| Tuckwheat yuzhu tea | Fagopyrum tataricum (L.) Gaertn. | seed | |
| Polygonatum odoratum (Mill.) Druce. | rhizome | ||
| Mulberry leaf black tea | Morus alba L. | leaf | |
| Camellia sinensis (L.) Kuntze | leaf and bud | ||
| Shunning tea | Morus alba L. | leaf | |
| Other composition unknown | - | ||
| Zhongyue Jiangsangao herbal tea | Crataegus pinnatifida Bunge | fruit | |
|
| seed | ||
| Sophora japonica L. | flower and alabastrum | ||
| Lycium barbarum L. | fruit | ||
| Polygonatum odoratum (Mill.) Druce. | rhizome | ||
| Pueraria lobata (Willd.) Ohwi | root | ||
| Ziziphus jujuba Mill. var. spinosa (Bunge) Hu ex H. F. Chou | seed | ||
|
| rhizome | ||
| Prunus mume (Sieb.) Sieb.et Zucc. | fruit | ||
|
| root and rhizome | ||
| Tianhan Xiaoke tea |
| root | |
| Cornus officinalis Sieb. et Zucc. | fruit | ||
| Ophiopogon japonicus (Thunb.) Ker Gawl. | rhizome | ||
| Rehmannia glutinosa (Gaertn.) DC. | rhizome | ||
|
| rhizome | ||
| Poria cocos (Schw.) Wolf | sclerotium | ||
| Diabetea tea |
| leaf and seed | |
|
| bark and fruit | ||
| Syzygium cumini (L.) Skeels | bark | ||
|
| bark | ||
|
| fruit | ||
|
| fruit | ||
|
| fruit | ||
| Tribulus terrestris L. | fruit | ||
| Trigonella foenum- graecum L. | seed | ||
| Cardiospermum halicacabum L. | leaf | ||
| Cinnamomum zeylanicum Blume | bark | ||
| Camellia sinensis (L.) Kuntze | leaf | ||
| Azadirachta indica A.Juss. | leafs and seed | ||
|
| bark and fruit | ||
| Self-developed herbal tea | Morus alba L. | leaf | |
| Crataegus pinnatifida f. major (N.E.Br.) W.Lee | fruit | ||
| Nelumbo nucifera Gaertn. | leaf | ||
| Camellia sinensis (L.) Kuntze | leaf and bud |
Dosage and usage of HTs.
| Trials | Herbal tea | Single dose (g)/time | Water for making herbal tea | Brewing time | Daily times | Total dosage (g)/day | Treament time | Others |
|---|---|---|---|---|---|---|---|---|
|
| Mulberry leaf tea | 6 | Hot water | 2 | 12 | 3 months | ||
| Yang et al., (2019) | Chamomile tea | 5 | Hot water (85–95°F) | - | 2 | 10 | 6 months | - |
| Rafraf M et al., (2015) | Chamomile tea | 10 | 100 ml Boiling water | 10 min | 2 | 20 | 2 months | Before lunch and dinner |
| Kaseb et al., (2018) | Gynostemma tea | 9 | 150 ml Hot water | 10 min | 3 | 27 | 1 month | Drink immediately after meals |
|
| Mate tea | 3 | - | - | 2 | 6 | 3 months | - |
|
| Kothala himbutu tea | 6.6 | 330 ml Boiling water | 10 min | 3 | 19.8 | 2 months | Before or during meals |
|
| Puda tea | - | - | - | 3 | - | 3 months | During meals |
|
| Rauvolfia-Citrus tea | - | - | - | - | 4 | 1 month | Daily way of drinking tea |
|
| Tuckwheat yuzhu tea | 8 | 300 ml Hot water | 2 | - | 6 months | After meals | |
| Liu et al., (2018) | 30 | 500 ml Water | at least 3 | - | 3 months | - | ||
| Fang 2001 | Shuning tea | - | - | - | 3 | - | 1 month | - |
| Han et al., (2015) | Zhongyue jiangsangao tea | 5–10 | Boiling water | Until the tea broth is tasteless | - | 3 months | - | |
|
| Tianhan diabetes tea | 1.8 | - | - | 2 | - | 2 months | - |
| Mahmoud F et al., 2016 | Diabetes tea | 2.72 | 250 ml Boiling water | 5 min | at least 4 | - | 3 months | - |
| Wen et al., (2018) | Self-developed herbal tea | 60 | Boiling water | - | 6 months |
Polyphenol content in herbs.
| HTs | Total polyphenols (mg/g) | Content of polyphenolic compounds (mg/g) | References | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Mulberry leaf tea | 13.36 | Astragalin | Chlorogenic acid | Kaempferol-glycoside | Quercetin-glycoside | Quercetin | Rutinum | - | Deng et al. (2021) |
| 0.09 | 1.106 | 0.434 | 0.502 | 1.099 | 0.814 | - | |||
| Chamomile tea | 100.5 | Apigenin | Apigenin-7-O-glucoside | Chlorogenic acid | Caffeic acid | Ferulic acid | Luteolin | Luteolin-7-O-glucoside |
|
| 1.22 | 9.93 | 13.25 | 0.77 | 2.85 | 2.6 | 6.51 | |||
| p-coumaric acid | Quercetin | Rutinum | - | - | - | - | |||
| 10.05 | 1.97 | 1.58 | - | - | - | - | |||
| Gynostemma tea | 75 | Isoquercitrin | Kaempferol | Para-hydroxybenzoic acid | Protocatechuic acid | Quercetin | Rutinum | - | Deng et al. (2019) |
| 0.36 | 0.82 | 0.04 | 0.15 | 1.36 | 10.07 | - | |||
| Yerba mate tea | 84.887 | Caffeic acid | Caffeoyl-glycosides | Caffeoylquinic acids | Caffeoyl-feruloylquinic acids | Caffeoyl-p-coumaroylquinic acids | Caffeoyl-sinapoylquinic acids | Dicaffeoylquinic acids |
|
| 0.231 | 2.9 | 54.134 | 0.548 | 0.053 | 0.091 | 16.608 | |||
| Feruloylquinic acids | Kaempferol-glycoside | Kaempferol-rhamnoglucoside | p-Coumaroylquinic acids | Quercetin-glycoside | Rutinum | - | |||
| 2.033 | 7.604 | 0.922 | 0.358 | 0.581 | 0.581 | - | |||
| Bitter melon | 224 | Catechin | Gallic acid | p-Coumaric | Tannic acid | - | - | - |
|
| 4.54* | 202* | 0.16* | 1.41* | - | - | - | |||
In this table, the total polyphenol content was determined by Folin-Ciocalteu colorimetric method and the phenolic compounds were analyzed by high performance liquid chromatography.
*The units of these values are mg/l.
FIGURE 1The effects of herbal teas in improving insulin resistance.
FIGURE 6The effect of herbal teas in type 2 diabetes mellitus.
Hypoglycemic mechanism of herbal tea based on single herbal tea.
| Herbal Tea Name | Extract | Animal model/ Cell | Duration | Effect | In vivo/vitro | References |
|---|---|---|---|---|---|---|
| Mulberry leaf tea | Mulberry leaf polysaccharide (MLPII) | Male Wistar rats; High-fat diet; injection of low-dose STZ | 6 weeks | Inhibiting the expression of PTP1B, activating the PI3K–AKT pathway and mitigating oxidative stress |
|
|
| Mulberry leaf | Male Sprague-Dawley rats; High-fat diet; injection of low-dose STZ | 13 weeks | inhibiting NEFA signaling pathway, improving the community structure of the intestinal microbiota |
|
| |
| Water extracts of mulberry leaf (WEM) | Sprague-Dawley male rats; high-fat and high-sugar diet; injection of low-dose STZ | 10 weeks | Inhibiting TLR2 signalling pathway, Stimulation of insulin signal pathway, Inhibit the production of TNF- α in serum |
|
| |
| mulberry leaf extract (MLE) | Male db/db mice | 8 weeks | stimulating glucose disposal in skeletal muscle cells via the PI3K/Akt and AMPK pathways |
| Ui-Jin Bae, et al. (2018) | |
| Mulberry leaf flavonoids (MLF) | Male db/db mice and db/m mice | 7 weeks | Ameliorating muscle glucose uptake and mitochondrial function in L6 muscle cells via AMPK/PGC/1α signaling pathway |
| Qinghai Meng, et al. (2020) | |
| Folium Mori extract (FME): contained the flavonoid and polyphenol components | Male Sprague-Dawley rats; high fat and high sugar diet; injection of STZ | 4 weeks | Activating the IRS-1/PI3K/Glut4 signalling pathway in skeletal muscles |
| Shengyu Cai, et al. (2016) | |
| Mulberry leaf extract (MA) | Mouse 3T3-L1 preadipocytes | 8 days | Stimulating adipogenesis and adiponectin secretion in 3T3-L1 cells |
|
| |
| Mulberry anthocyanin extract (MAE) | Male db/db mice and their nondiabetic lean littermates | 8 weeks | Activating of PI3K/AKT pathways, activating AKT phosphorylation and its downstream targets in insulin-sensitive tissues |
| Fujie Yan, et al. (2016) | |
| Mulberry leaf | Male Sprague-Dawley rats; High-fat diet; injection of low-dose STZ | 13 weks | Inhibition of NEFA signalling pathway transduction, restored the phyla Bacteroidetes and Proteobacteria and class Clostridia in the intestinal tract |
|
| |
| Mulberry leaf | Male db/db mice | 20 weeks | Maintain insulin levels and pancreatic β-cell mass by suppressing endoplasmic reticulum stress |
| Suthamwong P, et al. (2020) | |
| Mulberry leaf | Female Fischer rats; injection of alloxan monohydrate | 30 days | Decreasing MMP-2 levels and SOD/CAT ratio |
|
| |
| Mulberry leaf extracts (acetone-water (AE) and ethanol-water (EE)) | Male Wistar rats; High-fat diet; injection of STZ | 4 weeks | Reducing the uptake of Fe and Cu ions and mitigating oxidative events |
|
| |
| Mulberry leaf polysaccharide (MLPII) | Male Wistar rats; High-fat diet; injection of STZ | 5 weeks | Inhibiting pancreatic islet apoptosis via elevation of Bcl-2/Bax ratio, ameliorating insulin secretory capacity via restoration of PDX-1 nuclear localization and expression levels |
| Zhang et al. (2014) | |
| Morus alba leaves ethanol extract (MLE) | Male Sprague-Dawley (SD) rats; High-fat diet; injection of STZ | 8 weeks | Protect islet cells against dysfunction and death by inducing AMPK/mTOR-mediated autophagy |
| Ji et al. (2021) | |
| Cryptochlorogenic acid (CCA) | Sprague-Dawley (SD) rats; injection of STZ | 2 weeks | Inhibition of ferroptosis via activation of xc-/GPX4/Nrf2 and inhibition of NCOA4 |
| Zhou Y. (2020) | |
| Mulberry leaf | High-fat mice | 14 weeks | Inhibiting α-glucosidase activity; reducing the serum-free fatty acid (FFA), tumor necrosis factor-α (TNF-α), insulin, and glycated serum protein content and improving intestinal microbiota |
| Han X, et al. (2020) | |
| Mulberry anthocyanin extract (MAE) | HepG2 cells; male C57BL6/J genetic background (db/db) mice | 8 weeks | Activating PI3K/AKT pathways |
|
| |
| Puda tea | Bitter melon | Male OLETF rats | 6 weeks | Inhibiting NF-κB and JNK pathways |
|
|
| M. charantia ethanol extracts (MCE) | SPF-grade male SD rats; High-fat diet; injection of STZ | 8 weeks | Increase in hepatic glycogen, peripheral tissue’s GLUT-4 expression, and higher insulin sensitivity by down-regulating the expression of SOCS-3 and JNK. |
|
| |
| Bitter melon extract (BME) | NCI-H716 cells and IEC-18 cells | 6 h | Activating the TAS2R-signaling pathway in enteroendocrine cells and leading to GLP-1 secretion |
|
| |
| ethyl acetate (EtOAc)-soluble fraction | Male Lepob/ob (ob/ob) and Lep+/+ (wild-type) mice | 7 days | Increasing the levels of both insulin receptor mRNA and protein, decreasing the interleukin-1β mRNA and hepatic lipid accumulation in hepatocytes |
| Dwijayanti et al. (2020) | |
| Bitter melon protein extract | Male Wistar rats; High-fat diet; injection of low-dose STZ | 30 days | Anti-lipidemic and antioxidant |
| Poovitha et al. (2020) | |
| Saponins of Momordica charantia L. (SMC) | Male Kunming mice; High-fat diet; injection of low-dose STZ | 35 days | Activating AMPK/NF-κB signal pathway |
|
| |
| polysaccharides of Momordica charantia L. (PMC) | Male Kunming mice; High-fat diet; injection of low-dose STZ | 35 days | Repairing the damaged pancreatic-β cells and promoting antioxidantcapacity |
|
| |
| Momordica charantia | Rats; injection of STZ | 6 weeks | Activating pancreatic beta cells and protecting liver tissue |
|
| |
| Momordica charantia fruit pulp ethanolic extract | Wistar rats, injection of STZ | 28 days | Improved serum insulin and β-cell function |
| Hafizur et al. (2011) | |
| Momordica charantia extracts | Male albino rats | 90 min | Inhibiting of glucose-6-phosphatase and fructose-1, 6-bisphosphatase, enhancing principal enzyme G6PDH |
| Shibib et al. (1993) | |
| Momordica charantia seeds | Male Wistar rats, injection of Alloxan | 3 days | Contain an effective anti-hyperglycemic protein(s) |
| Choudhary et al. (2012) | |
| Chamomile Tea | Chamomile flowers extract (CFE) | Male C57BL/6 mice; Primary subcutaneous preadipocytes | 20 weeks; 6 weeks | Activing PPARs and other factors |
| Weidner et al. (2013) |
| luteolin | 3T3-L1 adipocytes | 24 h | Activating the PPARγ pathway and by acting at insulin signaling cascade |
| Ding et al. (2010) | |
| Chamomile flowers | Male Wistar rats, injection of STZ | 21 days | Inhibition of hepatic GP, inhibition of ALR2 |
|
| |
| Maltodextrin-Free Chamomile | The Caco-2 cell line | 4 days | Acute inhibition of GLUT2 and GLUT5 |
|
| |
| Gynostemma pentaphyllum Tea | polysaccharide (GPP) extracted from Gynostemma pentaphyllum herb | Kunming mice, injection STZ | 4 weeks | Enhancing the SOD, CAT, and GSH-Px activities, decreasing the MDA activity, improving the levels of IL-4 and IL-10, and decreasing the levels of TNF-α and IL-6 |
|
|
| Gynostemma pentaphyllum saponins (GPs) | Male Wistar rats; injection STZ | 40 days | Antioxidant effect |
|
| |
| Gynostemma pentaphyllum | Male C57 BL/6J mice, high-fat diet | 12 weeks | Improve glycolipid metabolism, and stimulate BAT activity, WAT browning and lipid β-oxidation, while decreasing the ratio of Firmicutes to Bacteroidetes and enhancing the abundance of Akkermansia muciniphila |
|
| |
| Damulin A and damulin B | L6 cells | Activating AMPK, increasing β-oxidation and glucose uptake, increasing GluT4 translocation to the plasma membrane |
| Nguyen et al. (2011) | ||
| gypenoside | Normal Wistar rats and Diabetic Goto-Kakizaki rats | Stimulating insulin secretion |
|
| ||
| a polysaccharide (GPP) | Specific-pathogen-free mice; | Inhibiting α-glucosidase activity, inhibiting the glucose absorption, affecting the protein expression of GLUT2 |
|
| ||
| Gynostemma pentaphyllum Extract | Male spontaneous type 2 diabetic Goto-Kakizaki rats | Stimulation of insulin release via K-ATP and L-type Ca2+ channels |
|
| ||
| Gynostemma pentaphyllum | Male Zucker fatty rats | 5 weeks | Inhibiting alpha-glucosidase activity, improving insulin receptor sensitivity |
| Megalli S, et al. (2006) | |
| G. pentaphyllum ethanol extract (GPE) | Male C57BL/KsJ-db/db mice | 5 weeks | Enhancing insulin secretion and its sensitivity, enhancing hepatic glucose utilization |
| Yeo et al. (2008) | |
| Salacia reticulata Tea | Salacia extract | Male TSOD mice and male TSNO mice | 8 weeks | Preventing obesity and associated metabolic disorders including the development of metabolic syndrome |
|
|
| Mangiferin | Male KK-Ay mice | 4 weeks | Down-regulating the gluconeogenic pathway through regulation of FBP expression |
|
| |
| Yerba Mate Tea | Yerba Mate | Male Wistar rats; injection of alloxan | 28 days | Decreasing the intestinal SGLT1 gene expression |
|
|
| Ilex paraguariensis tea | Male Wistar rats | 180 min | Inducing-insulin secretion; inhibiting |
|
| |
| Yerba Mate Tea | Male Swiss strain mice; high fat diets | 8 weeks | Inhibiting hepatic and muscle TNF-α and restoring hepatic insulin signalling |
|
| |
| Gallic acid | 3T3-L1 cells | 30 min | Increasing GLUT4 translocation and glucose uptake activity |
| Prasad CN, et al. (2010) |